何 宛玲

Medicine & Life Sciences

1. Taiwan 100%
2. Neuroblastoma 50%
3. Child 35%
4. Pediatrics 34%
5. Thalassemia 30%
6. Idiopathic Thrombocytopenic Purpura 30%
7. National Health Programs 28%
8. HLA Antigens 26%
9. Precursor Cell Lymphoblastic Leukemia-Lymphoma 25%
10. Lymphedema, Hereditary, II 24%
11. Neoplasms 23%
12. N-Acetylgalactosaminyltransferases 22%
13. Health Care Costs 21%
14. Atypical Teratoid Tumor 20%
15. Phenotype 19%
16. Deferasirox 19%
17. Galactosyltransferases 18%
18. Noonan Syndrome 18%
19. Glycosylation 18%
20. Brain Neoplasms 18%
21. Nasopharyngeal Neoplasms 17%
22. beta-Thalassemia 17%
23. Asparaginase 17%
24. Craniopharyngioma 16%
25. Population 16%
26. Hedgehogs 16%
27. Costs and Cost Analysis 16%
28. Ferrets 16%
29. Meniere Disease 16%
30. Adrenal Insufficiency 16%
31. Turner Syndrome 16%
32. IGF Type 1 Receptor 16%
33. Survival 15%
34. Mastoid 15%
35. Circulating Neoplastic Cells 15%
36. Intussusception 15%
37. Iron Overload 15%
38. Therapeutics 15%
39. Preclinical Drug Evaluations 15%
40. Patient Acceptance of Health Care 15%
41. Residual Neoplasm 14%
42. Second Primary Neoplasms 14%
43. Hospital Costs 14%
44. Nasopharyngeal Carcinoma 14%
45. Polysaccharides 14%
46. Drug Therapy 14%
47. Sarcoma 13%
48. Precision Medicine 13%
49. Chemoradiotherapy 13%